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Background: Living with a smoker is a key determinant of exposure to Second Hand Smoke (SHS) and its exposure
mainly occurs at home. Exposure to SHS from tobacco in the household predisposes to the development of
tuberculosis (TB) and outcome of the disease gets worse. We aim to develop and evaluate a behavioural
intervention ‘Smoke Free Homes’ (SFH) for TB patients that encourages them to negotiate a smoke free
environment within their homes.
Methods and design: The pilot individual randomised controlled trial of SFH will inform the design of a future
definitive trial. We will first develop SFH intervention using taxonomy of behaviour change techniques aimed at
encouraging families of non-smoking TB patients to implement smoking restrictions at home following a logic
model of the intervention. This will be followed by conducting a pilot randomised controlled trial of intervention
within the context of routine TB control programme. The eligible non-smoking TB patients will be randomised and
allocated to one of the two trial arms consisting of “individual based care” and “individual based care” plus
“supplementary support”. We aim to recruit 150 newly registered pulmonary TB patients from two selected TB
centres with 75 cases in each arm. The Primary outcome measure will be SFH of non-smoker TB patient by
validating through ‘Urine Cotinine’ test. We will also determine qualitatively the barriers and key drivers to the
creation of smoke free homes followed by developing a definitive trial.
Discussion: The male to female distribution of TB cases in Pakistan is almost equal whereas, tobacco use among
males is much high as compared to females in Pakistan. This reflects a strong possibility that women health can be
affected by men behaviour. Appropriate storage, restricted access and disposal arrangements for participant’s
personal details will be implemented. All ethical issues will be addressed. There will be no extra burden, financial or
otherwise, on the participants. They will not receive any financial incentive to participate in the study.
Trial registration: Trial Registration Number: ISRCTN83630841
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Second hand smoke
Second-hand smoke (SHS) is a combination of ‘side
stream’ smoke from the burning tip of a cigarette and
‘mainstream’ smoke exhaled by the smoker (Fielding and
Phenow 1988). Toxic chemicals from SHS cling to rugs,
curtains, clothes, food, furniture and other materials.* Correspondence: shine.org.pk@gmail.com
1Social and Health Inequalities Network, 862, St 13-C, E-11/4, Islamabad
44000, Pakistan
Full list of author information is available at the end of the article
© 2013 Safdar et al.; licensee Springer. This is a
Attribution License (http://creativecommons.or
in any medium, provided the original work is pThese toxins remain in the environment despite open
windows, fans or air filters; and can recycle back into
the air through the filters and coat the surfaces of
rooms, materials and smoker's belongings (World Health
Organization 2009). Second-hand smoke kills 600000
people each year and its exposure contributes to an in-
creased risk of cardiovascular diseases, lung cancer,
asthma and other respiratory diseases both in adults and
in children (World Health Organization 2009; Reddy
and Gupta 2004). Living with a smoker is a key deter-
minant of exposure to SHS and it occurs mainly inn open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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shows that 52% of the adults (rural-58%, urban-39%) are
exposed to SHS at home (Global Adult Tobacco Survey
(GATS) India 2010).
Tuberculosis, smoking and second hand smoke
Smoking was independently associated with significantly
increased risks of latent TB infection (LTBI). In cer-
tain populations, a greater risk of latent TB correspon-
ded with increased smoking exposure is also observed
(Horne et al. 2012). Exposure to SHS from tobacco in
the household predisposes to the development of tuber-
culosis (TB) (Leong 2010). In addition, outcomes in TB
patients gets worsen and risk of TB transmission in-
creases if there is a continued exposure to SHS from to-
bacco. There is evidence showing significant association
between SHS with drug resistant TB, severity of the
disease, patient delay smear conversion and death du-
ring or after treatment. A systematic review and meta-
analysis of observational studies reporting on relation of
TB and tobacco revealed substantial evidence that to-
bacco smoking is positively associated with TB and SHS
increases the risk of TB disease (Lin et al. 2007). Chil-
dren are at high risk of acquiring TB infection that lives
with adults who have had TB and are also smokers
(Patra et al. 2012; Singh et al. 2005; Alcaide et al. 1996).
Moreover, children who have had a recent TB infection
are also five times more likely to develop active TB di-
sease if exposed to SHS compared to children living in a
smoke free environment (Alcaide et al. 1996).
Smoking restrictions at home
It is crucial for better health of a family that their home
should be free from tobacco smoke, as around 90% of
the exposure to SHS takes place at home. This calls for
restrictions for smokers to smoke inside the home which
could be only achieved by rigorous work by identifying
the smoker and convincing him/her not to smoke inside
the home thus making a Smoke Free Home (SFH). Fac-
tors such as, younger age, being married, dislike for se-
cond hand smoke, and personal smoking behaviours
such as smoking every day, on occasions, etc were found
associated with having home and workplace smoking
bans (Heck et al. 2010). In few cases, parents with youn-
ger children in home appear to have higher uptake of
smoking bans than parents of older children or adoles-
cents (Merom & Rissel 2001; Martinez-Donate et al.
2009). A qualitative study conducted in Scotland re-
vealed that; the enablers to creating smoke free environ-
ment within the home include increasing awareness of
the risks of SHS particularly in relation to children,
desire to be seen as behaving in morally and socially
acceptable ways, social norms about the unacceptability
of smoking in the home among family and friendsincluding pressure from children. Whereas, the barriers
include limited understanding of and resistance to mes-
sages about the health risks of SHS, the need to smoke
and smoker identity, the home perceived as a private
space protected from public controls and sanctions, so-
cial norms among family and friends about the ac-
ceptability of smoking in the home (Philips et al. 2007).
Awareness of the risks of SHS, despite ambivalence
about health messages and the fluidity of smoking res-
trictions provides clear opportunities for public health
initiatives to support people attain smoke-free homes.
Research problem and justification
Pakistan is low income country; and is known to have a
5th highest TB burden and 9th highest tobacco use
among men in the world (World Health Organization
2012; Third WHO Report on the Global Tobacco Epi-
demic 2011). According to the World Health Survey,
Pakistan (2002-2003), in adults 18 years and above
prevalence of tobacco smoking was 19.1%, with males
being 32.4% and females 5.7% respectively. In a survey
conducted in one of the districts of Pakistan in 2008;
16.5% of the study population (33% men and 4.7%
women) were found using tobacco on daily basis. The
prevalence of exposure to SHS was found to be 56%
(35% were exposed to SHS on daily basis and the re-
maining were exposed few times a week) (Alam et al.
2008). A survey of women on tobacco use and exposure
to SHS during pregnancy showed that in Pakistan the
SHS exposure in women was high. 91.6% homes allowed
smoking indoors, 49.9% were frequently/always exposed
to tobacco smoke indoors and 51.4% reported their
young children being frequently/always exposed to to-
bacco smoke indoors (Bloch et al. 2008).
The government of Pakistan being the signatory of
Framework Convention for Tobacco Control (FCTC)
has already taken a number of important steps for effec-
tive tobacco control in the country including restriction
on advertisement, health warning on cigarette packs,
ban on sales to minors, mass media awareness, and leg-
islations. According to current policy smoking is banned
in health and educational facilities, offices and on public
transportation. However, there are no clear guidelines
and evidence is lacking on how to ensure a smoke free
environment inside home for non smokers. There is cur-
rently no evidence on interventions, which could help to
reduce exposure to SHS for non-smoker TB patients
and help improve their TB outcomes by making their
homes smoke free. This embarks on a need for inno-
vative solutions within the context of TB care delivery
which could provide evidence for creating SFH for TB
patients which will be likely the main contribution of
our proposed study. Similar interventions are being tes-
ting in educational settings (Siddiqi et al. 2010), but not
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patients. This is for the first time a pilot Randomized
Control Trial (RCT) is going to be implemented in TB
patients in making their home smoke free. Furthermore,
such approaches have been highlighted in the declar-
ation on Non Communicable Disease (NCDs) in United
Nations summit held in September, 2011 (UN Sumit
2011) and also in World Health Organization ‘MPOWER
package’ (The MPOWER package 2008) and The Union
‘Smoking cessation and smoke free environment for TB
patients’ (Bissell et al. 2010).
Research questions
This pilot trial has been designed to answer the fol-
lowing research questions;
1. What behaviour change techniques are relevant and
appropriate to be used in the development of
‘Smoke Free Homes’ intervention?
2. What is the feasibility and fidelity of implementing
‘Smoke Free Homes’ intervention in TB patients?
3. What is the proportion of non-smoker TB patients
among all registered TB cases and what is the
smoking behaviour of residents in their homes?
4. What is the rate and reasons of refusal to participate
in the research by the non-smokers with smoker in
home?
5. What are the recruitment and attrition rates for
participants?
6. What is the likely effect size in relation to the
primary outcome measure i.e. reduction in the
exposure to second-hand smoke validated by a
urinary cotinine test after 2 months of TB
treatment?
7. What is the feasibility and acceptability of measuring
the primary outcome?
8. What are the barriers of change reported by the TB
patient during follow-up?
9. What is the feasibility of measuring TB treatment
outcomes among trial participants?
General objectives
The purpose is to improve outcomes among those TB
patients who are non-smokers themselves but are ex-
posed to SHS and reduce the risk of TB transmission to
other members of the household by encouraging families
to make their homes smoke free.
Specific objectives
We aim to develop and evaluate a behavioural inter-
vention ‘Smoke Free Homes’ for TB patients. SFH for
TB patients’ is a behavioural intervention that encou-
rages TB patients to negotiate a smoke free environment
within their homes. Our specific objectives are:1. To develop a behaviour change intervention ‘Smoke
Free Homes’ aimed at encouraging families of newly
registered non-smoking TB patients to implement
smoking restrictions at home (Phase I).
2. To conduct a pilot randomised controlled trial of
‘Smoke Free Homes’ intervention within the context
of routine TB control programme (Phase II).
3. To determine the barriers and key drivers to the
creation of SFH (Phase III).
4. To develop and submit a proposal on a definitive
trial based on the pilot trial findings (Phase IV).
Methodology
Design
This is a pilot individual randomised controlled trial of
SFH that will inform the design of a future definitive
trial. The definitive trial will assess the effectiveness and
cost effectiveness of SFH intervention in reducing SHS
exposure for non-smoking TB patients compared to rou-
tine care. We will first develop SFH intervention using
taxonomy of behaviour change techniques (Michie &
Abraham 2008) in order to help TB patients in negotia-
ting smoking restriction at home. The selected Behaviour
Change Taxonomy (BCTs) will guide the development of
the content of the intervention tools likely to be in the
form of a flip chart and a leaflet. This will be designed to
inform and support TB patient to negotiate smoking re-
strictions in their homes.
Objective 1
To develop a behaviour change intervention ‘Smoke Free
Homes’ aimed at encouraging families of non-smoking
TB patients to implement smoking restrictions at home.
(Phase I).
Key activities
The process of intervention development will run over
6 months period that will also include developing and
finalising trial protocol and research tool. The develop-
ment will take place in a phased manner following a
logic model of the intervention (Figures 1 and 2). The
logic model provides a pathway and focus to develop
educational materials that improve knowledge, attitude,
motivation, build confidence and negotiation skills, and
increase intention to act with further reinforcement at
the follow-up. It will be a two-pronged intervention
where stage-1 will focus on the interaction between ‘care
provider and TB patient’ and stage-2 on the inter-
action between ‘non-smoking TB patient and smoker(s)
at home’.
The process of development will include organising
a Development Core Group (DCP). The members
will include representatives from the national TB con-
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Figure 1 Intervention stage 1: health professional to non-smoking TB patient (who are exposed to SHS at home).
Safdar et al. SpringerPlus 2013, 2:556 Page 4 of 9
http://www.springerplus.com/content/2/1/556communications expert, psychologist and the research
team. The group will review the draft materials and ap-
prove these for piloting.
The intervention and its components
The SFH intervention will be based on behaviour change
taxonomy (BCTs). The intervention will follow the fol-
lowing steps to bring about a change in the behaviour of
the smoker living with the non-smoking TB patient: a)
providing information to the non-smoking TB patient;
b) helping him/her to formulate a strategy to change be-
haviour of the smoker and help sustaining that change;
and c) finally giving a clear call to action for behaviour
change.
Outputs
1. A complete set of refined SFH intervention materials
including an illustrative flip chart to inform and
encourage non-smoking TB patient to negotiate
smoking restrictions at home.Figure 2 Intervention stage 2: TB patients to smokers in the home.2. An illustrative leaflet for the TB patient that will
help him/her to start a conversation on the topic of
making the home smoke free.
3. The intervention package will also include
supplementary support which includes mobile
phone standardized text messages or letter (where
mobile phone is not available) on a weekly basis, to
be sent to smoker at home in the arm 2 of the trial.
Figures 1 and 2 presents the logic model which pre-
sents the flow of events and the expected outcomes.
Objective 2
To conduct a pilot randomised controlled trial of
‘Smoke Free Homes’ intervention within the context of
routine TB control programme (Phase II).
Hypothesis
We hypothesis that the SFH educational materials with
or without supplementary support (mobile phone text
message ‘SMS’ or letter to smoker(s) at home on weekly
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of exposure to tobacco smoke at home in non-smoking
TB patients living with smoker(s). The option of supple-
mentary support of SMS or letter seems more powerful
as this may persuade the smoker at home in imple-
menting smoking restriction in home.
Setting
The trial protocol will be implemented and evaluated in
two selected TB centres (within the premises of district
hospitals) in the public sector which are designated
TB diagnostic centres by the National TB Control Pro-
gramme (NTP), and serve both rural and urban settings
in two districts of the province of Punjab-Pakistan.
These centres are routinely staffed by a doctor, desig-
nated TB facilitator and a laboratory technician. They
are also equipped with a basic microbiology laboratoryFigure 3 Trial flow chart.for sputum smear microscopy. These TB centres are
busy out-patient settings and on an average deals with
about 75-100 patients a day with limited human re-
source. A TB suspect is screened by the doctor (trained
by NTP on TB case management protocols) supported
by investigations and if diagnosed as TB case is regis-
tered by the TB facilitator (a paramedic trained on TB
case recording and reporting) and offered six months of
TB treatment. The follow-up of the case is also the res-
ponsibility of the doctor and the TB facilitator.
Study design and sample
The design of the trial is an individual randomised con-
trolled trial (RCT). Figure 3 represents the overall flow
of the events in the trial. To deliver ‘Smoke Free Home’
intervention, the eligible non-smoking TB patients will
be randomised and allocated to one of the two trial
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intervention materials, whereas Arm 2 consists of “indi-
vidual based care” plus “supplementary support” i.e. mo-
bile phone text message or letter to smoker(s) at home
with an assumption that it would persuade more the
smoker to smoke outside the home. As it is a pilot RCT,
we aim to recruit 150 newly registered pulmonary TB
patients from two selected TB centres with 75 cases in
each arm.
Inclusion criteria
– Should be a registered case of new pulmonary TB,
either sputum smear positive or negative ( new TB
patients are defined as those who have no history of
prior TB treatment or who received less than
1 month of anti-TB drugs, regardless of whether their
smear or culture results are positive or not).
– Should be a non-smoker.
– Have not taken part in a ‘Smoke Free Homes’
activity before.
– Residing within the same district.
– Aged more than 10 years.
– Lives with at least one other person who smokes
tobacco on a regular basis without any restrictions
in the house.
Recruitment
The recruitments will start in November 2012 and will
continue until we recruit the targeted number of partici-
pants. Each participant in the cohort will be followed-up
for 6 months after the inclusion in trial. It will be led by
the TB facilitator in the TB centre. The following pro-
cess will be followed to recruit the participants. The TB
facilitator will screen all newly registered pulmonary TB
patients for inclusion in the trial. The TB facilitator will
first confirm that the TB patient is a) case of new pul-
monary TB by reviewing the TB register, b) non-smoker
by prompting; do you smoke tobacco? such as cigarette,
beeri, huqa, cigar, any other (once daily a cigarette/pack,
huqa session(s) or any other form of tobacco), c) resi-
dent of the same district by reviewing the TB register,
and d) aged more than 10 years by reviewing the TB
register. All such patients who meet the above criteria
and are eligible will be referred to research assistant
(RA) for further trial procedures. The TB facilitator will
continue offering TB care to all registered patient as per
NTP protocol, irrespective of their trial status.
Trial registration and informed consent
This will be led by the RA based in the TB centre. The
RA will record patient basic information, eligibility and
consent. If the patient meets the eligibility criteria the
RA will continue with informed consent process.RA will seek written informed consent from all partici-
pants who full fill the eligibility criteria of the trial activ-
ities. The RA will use the ‘Information Sheet’ to inform
the eligible patients about the nature and purpose of
the trial; potential risks and benefits of participation
in the trial including consequences of participating
and not participating in the trial. If the patient does
not agree to participate the RA will not proceed with
the registration process and will record the reasons
for non participation on the specified place in the
registration form. The patient will continue TB rou-
tine care management at the health facility. We are
not offering any personal incentive to the participant
for taking part in the study.Patient randomisation
The research team will draw simple randomisation ta-
bles where the unit of randomisation will be individuals.
The 150 cases will be randomised in to two arms with
75 cases in each arm. The record of randomisation codes
and allocation will be maintained by the principal inves-
tigator. Once randomised, a participant cannot be with-
drawn from the trial. The RA will remain blinded to the
fact regarding which arm has been allocated to the pa-
tient and will deliver the individual based care to all pa-
tients registered in the trial. Once a patient will be
registered the information will be send by the RA to the
principal investigator who will allocate the arm and in-
form the co-investigator. The SMS or letter to the arm 2
registered patients will be send by the researcher away
from the TB centre. The trial register will be kept in re-
searcher office under lock and key and only the principal
investigator will have access to it.Withdrawal
There are possibilities that a patient may decide to dis-
continue his/her participation in the trial at any stage
with or without information. In case, the TB patient
discontinues participation in trial during the first month,
he/she will be declared non-adherent. Non adherence is
defined as any departure from the current approved ver-
sion of the trial protocol, so that the intervention is not
completed. The RA will attempt to retrieve all such
patients. In case, the TB patient discontinues partici-
pation in trial after the first month, he/she will be de-
clared as ‘loss to follow up’. The RA will not attempt
to retrieve such patients; however, he will record their
TB outcomes at 6 months. The retrieval process will
be followed by the TB facilitators as per the TB con-
trol protocols. In case, a participant withdraws con-
sent to participate, no further data will be collected
from them. However, previously collected data will be
used in analyses.
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The data will be recorded on trial registration by the
RA. The co-investigator will be responsible for maintai-
ning the quality of data collected. A code plan will be
prepared to help data entry using SPSS software and the
same will be used for analysis.Outcome assessments
All outcomes will be measured after the intervention in
each of the study’s arms. The Primary outcome will be
SFH of non-smoker TB patient by validating through
‘Urine Cotinine’ test. During the trial process two urine
samples will be collected for cotinine testing at time of
registration ‘0 month’ and at completion of ‘2 month’
of treatment. The first test will establish the base line
where as the test at 2 month will be used to validate the
effect of intervention. The urine cotinine testing will be
done by the laboratory technician in the TB clinic who
will receive relevant training on the conduct of the test
and its interpretation. The RA will be kept blinded to
the results of urine cotinine and the results will be col-
lected by the researchers directly from the laboratory.
The Secondary outcomes will be mainly patient cure
rates. All type of patient treatment outcome will be doc-
umented including; cured, completed, default, died, failure
and transfer out.Data monitoring
Data will be monitored for quality and completeness by
the principal and co-investigator using verification, va-
lidation and checking processes. Missing data will be
pursued until study end unless they are data obtained by
participant contact and this would cause distress.Data analysis
Summaries of the baseline characteristics of participants
will be presented by trial arm, and recruitment and attri-
tion rates will be reported. Although it is a pilot trial
and the ample size has not been powered to estimate the
likely effect size of the primary outcome, a comparison
between the two intervention arms will be undertaken
to determine the difference in the outcome between two
arms adjusting for health centre. Differences of the se-
condary outcome between the two arms will also be
reported. Analyses will be conducted under the principle
of intention to treat, with individual participant as the
primary unit of analysis.Objective 3
To determine the barriers and key drivers to the creation
of smoke free homes. (Phase III).Key activities
We will require an in-depth understanding of the way
the intervention has worked within the household set-
ting. This implies the knowledge to be gained from the
patients on actual drivers and barriers to effectively im-
pose smoking restrictions in the home. We would be in-
terested in understanding in which ways the patient felt
supported in their efforts to keep their home free of
smoke, which aspect of the SFH materials were most
helpful, which factors motivated the smokers at home to
change their behaviour, and which were their main con-
straints. Since this phase will be post intervention, it
would be preferable to use semi structured interviews
with key informants to gain this understanding.
Participants
The participants will be those from which we have re-
ceived follow-up urine cotinine result i.e. at the end of
2 months of treatment. There will be 12 participants, six
from each arm and representing both hospitals and will
be grouped as;
– Patients who were successful in imposing smoking
restriction in their homes.
– Patients who were unsuccessful in imposing
smoking restriction in their homes.
– Patients who were partially successful in imposing
smoking restriction in their homes.
Data collection
We will use an interview checklist and all communica-
tions will be tape-recorded and transcribed.
Data analysis
The data will be categorized for thematic analysis.
Outputs
The understanding gained from this activity will be used
to further refine the intervention of SFH individual based
care and supplementary support to take account of bar-
riers and enablers to administer smoking restrictions in
homes. Moreover, the findings will be also helpful in de-
signing the definitive trial.
Objective 4
To develop and submit a proposal on a definitive trial
based on the pilot trial findings. (Phase IV).
Key activities
The findings of the trial will be used to formulate and
submit a definitive trial. The definitive trial will have
a statistically valid sample size considering all the is-
sue such as recruitment and attrition rate, etc based
on pilot trial. The definitive trail will be developed in
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We will not make any specific efforts to increase user
participation. However, the RA will keep a close liaison
with the TB facilitator and will be trained to communi-
cate the health benefits of the intervention to the TB pa-
tients while requesting for consent.
Gender and status considerations
The gender and status are key determinants of the pro-
posed change in smoking behaviour in home. The male
to female distribution of TB cases in Pakistan is almost
equal whereas, tobacco use among males is much high
as compared to females in Pakistan. This reflects a
strong possibility that women health can be affected by
men behaviour. The gender and relationship/status of
the TB patient and that of the smoker at home, may
create conflicting scenarios within the household setting.
We will conduct interviews of both males and females
to capture gender perspectives and status implications in
administering smoking restrictions in the home.
Confidentiality and data protection issues
All the patient data files, paper and soft copy, will be
kept confidential. The patient name will not be entered,
instead a unique identification number will be used to
identify the patients. In this research it will be the pa-
tient TB registration number which is standardized by
the NTP. During the data entry patient identification
number will be used which can only be tracked backed
if required. All the information on paper and computer
will be held securely with the principal investigator in
Islamabad office. Appropriate storage, restricted access
and disposal arrangements for participant’s personal de-
tails will be implemented.
Ethical considerations
The research questions address a priority need for non
smoking TB patients in Pakistan as they are commonly
exposed to second hand smoke. We understand that
children’s (10-18 years) participation in such studies
raises issues around incompetence, vulnerability and
powerlessness. We will ensure that our approach to chil-
dren is participatory and as non-intrusive and accommo-
dating as possible. There may be possible issues with
smoker in the household receiving letters and SMS mes-
saging which could provoke domestic disturbance. RA
will check with patient as part of consent that if the
team communicates with the smoker will it cause any is-
sues. Also if patients want to keep his or her illnessconfidential in which case it would not be mentioned in
the message. No participating TB patient will be de-
prived of any service that she or he would ordinarily re-
ceive at the TB centre. There will be no extra burden,
financial or otherwise, on the participants. The TB patient
and their families will not incur any cost for participating
in this study. They will not receive any financial incentive
to participate in the study. The messages in the ‘Smoke
Free Homes’ intervention is not harmful and will be in
Urdu language. All data collected will be confidential. The
TB centre management will be provided complete infor-
mation about the study.Ethical clearance
The trial has received ethical clearance from the ‘National
Bioethics Committee’ Pakistan.Trial status
The patient’s recruitment was started in November 2012,
and 150 patients recruitment was completed in end May
2013. Each recruited patient has to be followed-up for
6 months after the inclusion in trial. It is expected that the
last patient registered in May, 2013 will have 6 month
follow-up completed by Nov-Dec 2013 after which all data
will be retrieved from the field sites and data entry and
cleaning will start.Results and discussion
This is a protocol for a pilot individual randomised con-
trolled trial of ‘Smoke Free Homes’ intervention and
therefore, its findings will inform a future definitive trial.
The potential impact of this research is likely to be high
as it addresses a key public health priority, uses an in-
novative approach, and engages with TB patients and
their families that are generally not engaged in research
and not been done in Pakistan. We will publish papers
relating to this trial that will include mainly the trial
protocol, findings on the feasibility and fidelity of inter-
vention and a qualitative study. We will produce a short
summary of the results that can be distributed to all trial
participants, including TB facilitators, doctors and the
management of TB centre. The University of York, Na-
tional TB control programme and Tobacco cell will be a
part of the dissemination process. We will also dissemi-
nate the research findings in national and international
scientific conferences and policy meetings.
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